Robert L. Nussbaum - Apr 9, 2022 Form 4 Insider Report for Invitae Corp (NVTA)

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Stock symbol
NVTA
Transactions as of
Apr 9, 2022
Transactions value $
$0
Form type
4
Date filed
4/12/2022, 04:24 PM
Previous filing
Mar 16, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Award $0 +169K +69.87% $0.00 410K Apr 9, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issuable upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3 of the total award vesting on each of May 15, 2023, 2024 and 2025, subject to continued service with the issuer through the applicable vesting dates.
F2 Includes an aggregate of 259,997 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.